CorMedix (CRMD) Change in Receivables (2015 - 2025)
CorMedix (CRMD) reported Change in Receivables of $12.4 million for Q4 2025, down 63.97% on a YoY basis from $34.4 million in Q4 2024, and down 85.8% sequentially from $87.3 million in Q3 2025.
CorMedix (CRMD) Change in Receivables (2015 - 2025) Analysis & Trends
CorMedix (CRMD) has 10 years of Change in Receivables data on file, last reported at $12.4 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 63.97% year-over-year to $12.4 million; the trailing twelve-month figure through Dec 2025 stood at $90.9 million (up 76.26% YoY), and the FY2025 full-year result was $90.9 million, up 75.56% from the prior year.
- Change in Receivables declined to $12.4 million in Q4 2025, from $87.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $87.3 million in Q3 2025 to a low of -$11.7 million in Q2 2025.
- A 4-year average of $10.2 million and a median of $21337.0 in 2021 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1825.73% in 2021, while the deepest fall reached 1290.7% in 2021.
- Tracing CRMD's Change in Receivables over 4 years: stood at $47354.0 in 2021, then tumbled by 99.07% to $440.0 in 2022, then soared by 7818889.55% to $34.4 million in 2024, then sank by 63.97% to $12.4 million in 2025.
- Business Quant data shows CRMD's Change in Receivables at $12.4 million in Q4 2025, $87.3 million in Q3 2025, and -$11.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 12.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.40 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Jun 30, 2025 | -11.71 Mn |
| Jun 30, 2025 | -11.71 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 34.40 Mn |
| Dec 31, 2024 | 34.40 Mn |
| Sep 30, 2024 | 17.18 Mn |
| Sep 30, 2024 | 17.18 Mn |
| Dec 31, 2022 | 440.00 |
| Dec 31, 2022 | 440.00 |
| Sep 30, 2022 | 1,155.00 |
| Sep 30, 2022 | 1,155.00 |
| Jun 30, 2022 | -1,864.00 |
| Jun 30, 2022 | -1,864.00 |
| Mar 31, 2022 | -41,874.00 |
| Mar 31, 2022 | -41,874.00 |